These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25711510)

  • 41. Central sleep apnea in a geriatric patient treated with aripiprazole.
    Kohen I; Sarcevic A
    Am J Ther; 2009; 16(2):197-8. PubMed ID: 19300045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Worsening of psychosis with aripiprazole.
    Eatt J; Varghese ST
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E20. PubMed ID: 24763776
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of aripiprazole in adolescents with a history of lupus-associated psychosis and refractory psychiatric manifestations.
    Muscal E; Bang L; Mian A; Harris TB
    J Psychiatr Pract; 2011 May; 17(3):212-6. PubMed ID: 21587001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Change in sexual dysfunction with aripiprazole: a switching or add-on study.
    Mir A; Shivakumar K; Williamson RJ; McAllister V; O'Keane V; Aitchison KJ
    J Psychopharmacol; 2008 May; 22(3):244-53. PubMed ID: 18308789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency.
    Garel N; Joober R
    J Psychiatry Neurosci; 2019 Nov; 44(6):E31-E32. PubMed ID: 31657537
    [No Abstract]   [Full Text] [Related]  

  • 46. Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: an open-label study.
    Liu CC; Chien YL; Hsieh MH; Hwang TJ; Hwu HG; Liu CM
    J Clin Psychopharmacol; 2013 Feb; 33(1):18-23. PubMed ID: 23277261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does Combining Aripiprazole With Other Antipsychotics Worsen Psychosis?
    Mahgoub N
    J Clin Psychopharmacol; 2015 Aug; 35(4):470-1. PubMed ID: 26061610
    [No Abstract]   [Full Text] [Related]  

  • 48. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.
    Cookson J; Hodgson R; Wildgust HJ
    J Psychopharmacol; 2012 May; 26(5 Suppl):42-51. PubMed ID: 22472310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aripiprazole.
    Prommer E
    Am J Hosp Palliat Care; 2017 Mar; 34(2):180-185. PubMed ID: 26589880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aripiprazole is associated with early onset of Tardive Dyskinesia like presentation in a patient with ABI and psychosis.
    Zaidi SH; Faruqui RA
    Brain Inj; 2008 Jan; 22(1):99-102. PubMed ID: 18183513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Acute Dystonia due to Aripiprazole Use in Two Children with Autism Spectrum Disorder in the First Five Years of Life].
    Küçükköse M; Kabukçu Başay B
    Turk Psikiyatri Derg; 2017; 28(1):71-73. PubMed ID: 28291301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aripiprazole: an overview of a novel antipsychotic.
    Uzun S; Kozumplik O; Mimica N; Folnegović-Smalc V
    Psychiatr Danub; 2005 Jun; 17(1-2):67-75. PubMed ID: 16395846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacogenetics of aripiprazole-induced hyperprolactinemia: what do we know?
    Koller D; Abad-Santos F
    Pharmacogenomics; 2020 Jun; 21(9):571-574. PubMed ID: 32397867
    [No Abstract]   [Full Text] [Related]  

  • 55. The advantage of using 3-week data to predict response to aripiprazole at week 6 in first-episode psychosis.
    Park JI; Cho DH; Hahn SW; Jeong B; Kim JH; Kim SW; Koo MS; Lee SH; Lee SJ; Lee YH; Park JI; Rho SH; Chung YC
    Int Clin Psychopharmacol; 2014 Mar; 29(2):77-85. PubMed ID: 23970176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program.
    Corbeil O; Corbeil S; Dorval M; Carmichael PH; Giroux I; Jacques C; Demers MF; Roy MA
    CNS Drugs; 2021 Apr; 35(4):461-468. PubMed ID: 33713298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of Extrapyramidal Adverse Events With Aripiprazole.
    Etminan M; Procyshyn RM; Samii A; Carleton BC
    J Clin Psychopharmacol; 2016 Oct; 36(5):472-4. PubMed ID: 27580493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two Cases of De Novo Pathological Gambling Associated With Aripiprazole.
    Chen HY; Ma CH; Liu CC
    Clin Neuropharmacol; 2019; 42(3):101-102. PubMed ID: 31082834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aripiprazole-induced persistent hiccup: a case report and review of the literature.
    Serafini G; Piccinini G; Visimberga S; Cervetti A; Belvederi Murri M; Monacelli F; Pompili M; Amore M
    Psychiatr Danub; 2019 Mar; 31(1):26-31. PubMed ID: 30948686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.